Logo image of ABL.DE

ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis

FRA:ABL - US0028241000 - Common Stock

112.08 EUR
-0.94 (-0.83%)
Last: 9/3/2025, 11:36:04 AM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ABL. ABL was compared to 57 industry peers in the Health Care Equipment & Supplies industry. ABL gets an excellent profitability rating and is at the same time showing great financial health properties. ABL has a correct valuation and a medium growth rate. These ratings would make ABL suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ABL was profitable.
In the past year ABL had a positive cash flow from operations.
Each year in the past 5 years ABL has been profitable.
In the past 5 years ABL always reported a positive cash flow from operatings.
ABL.DE Yearly Net Income VS EBIT VS OCF VS FCFABL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

ABL's Return On Assets of 16.64% is amongst the best of the industry. ABL outperforms 92.98% of its industry peers.
ABL has a better Return On Equity (27.65%) than 94.74% of its industry peers.
The Return On Invested Capital of ABL (9.37%) is better than 80.70% of its industry peers.
ABL had an Average Return On Invested Capital over the past 3 years of 10.45%. This is in line with the industry average of 8.81%.
Industry RankSector Rank
ROA 16.64%
ROE 27.65%
ROIC 9.37%
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ABL.DE Yearly ROA, ROE, ROICABL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

ABL's Profit Margin of 32.43% is amongst the best of the industry. ABL outperforms 98.25% of its industry peers.
In the last couple of years the Profit Margin of ABL has grown nicely.
Looking at the Operating Margin, with a value of 17.85%, ABL is in the better half of the industry, outperforming 78.95% of the companies in the same industry.
ABL's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 56.20%, ABL is in line with its industry, outperforming 54.39% of the companies in the same industry.
In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
Industry RankSector Rank
OM 17.85%
PM (TTM) 32.43%
GM 56.2%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
ABL.DE Yearly Profit, Operating, Gross MarginsABL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ABL is still creating some value.
Compared to 1 year ago, ABL has about the same amount of shares outstanding.
The number of shares outstanding for ABL has been reduced compared to 5 years ago.
ABL has a better debt/assets ratio than last year.
ABL.DE Yearly Shares OutstandingABL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABL.DE Yearly Total Debt VS Total AssetsABL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

ABL has an Altman-Z score of 5.89. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.89, ABL belongs to the top of the industry, outperforming 91.23% of the companies in the same industry.
The Debt to FCF ratio of ABL is 1.98, which is an excellent value as it means it would take ABL, only 1.98 years of fcf income to pay off all of its debts.
ABL has a better Debt to FCF ratio (1.98) than 84.21% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that ABL is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.26, ABL perfoms like the industry average, outperforming 59.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 1.98
Altman-Z 5.89
ROIC/WACC1.1
WACC8.51%
ABL.DE Yearly LT Debt VS Equity VS FCFABL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

A Current Ratio of 1.82 indicates that ABL should not have too much problems paying its short term obligations.
The Current ratio of ABL (1.82) is comparable to the rest of the industry.
A Quick Ratio of 1.30 indicates that ABL should not have too much problems paying its short term obligations.
ABL's Quick ratio of 1.30 is fine compared to the rest of the industry. ABL outperforms 64.91% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.3
ABL.DE Yearly Current Assets VS Current LiabilitesABL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.11%, which is quite good.
ABL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.59% yearly.
Looking at the last year, ABL shows a small growth in Revenue. The Revenue has grown by 5.85% in the last year.
Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.63% on average per year.
EPS 1Y (TTM)10.11%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%10.53%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%7.37%

3.2 Future

ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.87% yearly.
Based on estimates for the next years, ABL will show a small growth in Revenue. The Revenue will grow by 7.08% on average per year.
EPS Next Y11.28%
EPS Next 2Y10.75%
EPS Next 3Y10.76%
EPS Next 5Y9.87%
Revenue Next Year6.48%
Revenue Next 2Y7.16%
Revenue Next 3Y7.22%
Revenue Next 5Y7.08%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABL.DE Yearly Revenue VS EstimatesABL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B
ABL.DE Yearly EPS VS EstimatesABL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.62, which means the current valuation is very expensive for ABL.
Based on the Price/Earnings ratio, ABL is valued a bit cheaper than the industry average as 68.42% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ABL to the average of the S&P500 Index (26.90), we can say ABL is valued inline with the index average.
With a Price/Forward Earnings ratio of 22.79, ABL is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as ABL.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.52, ABL is valued at the same level.
Industry RankSector Rank
PE 26.62
Fwd PE 22.79
ABL.DE Price Earnings VS Forward Price EarningsABL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ABL.
Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than the industry average as 68.42% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 33.53
EV/EBITDA 21.67
ABL.DE Per share dataABL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABL does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)2.36
PEG (5Y)3.51
EPS Next 2Y10.75%
EPS Next 3Y10.76%

4

5. Dividend

5.1 Amount

ABL has a Yearly Dividend Yield of 1.80%.
Compared to an average industry Dividend Yield of 2.32, ABL pays a bit more dividend than its industry peers.
Compared to the average S&P500 Dividend Yield of 2.32, ABL is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.8%

5.2 History

On average, the dividend of ABL grows each year by 11.40%, which is quite nice.
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
ABL.DE Yearly Dividends per shareABL.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

28.42% of the earnings are spent on dividend by ABL. This is a low number and sustainable payout ratio.
ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.42%
EPS Next 2Y10.75%
EPS Next 3Y10.76%
ABL.DE Yearly Income VS Free CF VS DividendABL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
ABL.DE Dividend Payout.ABL.DE Dividend Payout, showing the Payout Ratio.ABL.DE Dividend Payout.PayoutRetained Earnings

ABBOTT LABORATORIES

FRA:ABL (9/3/2025, 11:36:04 AM)

112.08

-0.94 (-0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-17 2025-07-17/bmo
Earnings (Next)10-14 2025-10-14/bmo
Inst Owners80.67%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap195.07B
Analysts78.86
Price Target123.63 (10.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.8%
Yearly Dividend1.9
Dividend Growth(5Y)11.4%
DP28.42%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.08%
Min EPS beat(2)-0.58%
Max EPS beat(2)0.73%
EPS beat(4)1
Avg EPS beat(4)-0.34%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)4
Avg EPS beat(8)0.55%
EPS beat(12)8
Avg EPS beat(12)3.44%
EPS beat(16)12
Avg EPS beat(16)8.67%
Revenue beat(2)0
Avg Revenue beat(2)-0.85%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-0.81%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.19%
Revenue beat(8)1
Avg Revenue beat(8)-0.29%
Revenue beat(12)5
Avg Revenue beat(12)0.8%
Revenue beat(16)9
Avg Revenue beat(16)2.75%
PT rev (1m)-1.39%
PT rev (3m)-2.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.26%
EPS NY rev (1m)-0.3%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 26.62
Fwd PE 22.79
P/S 5.27
P/FCF 33.53
P/OCF 25.14
P/B 4.49
P/tB 10.98
EV/EBITDA 21.67
EPS(TTM)4.21
EY3.76%
EPS(NY)4.92
Fwd EY4.39%
FCF(TTM)3.34
FCFY2.98%
OCF(TTM)4.46
OCFY3.98%
SpS21.27
BVpS24.95
TBVpS10.21
PEG (NY)2.36
PEG (5Y)3.51
Profitability
Industry RankSector Rank
ROA 16.64%
ROE 27.65%
ROCE 10.91%
ROIC 9.37%
ROICexc 10.45%
ROICexgc 19.79%
OM 17.85%
PM (TTM) 32.43%
GM 56.2%
FCFM 15.72%
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexcg growth 3Y-24.08%
ROICexcg growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 1.98
Debt/EBITDA 1.19
Cap/Depr 72.02%
Cap/Sales 5.25%
Interest Coverage 250
Cash Conversion 83.38%
Profit Quality 48.47%
Current Ratio 1.82
Quick Ratio 1.3
Altman-Z 5.89
F-Score7
WACC8.51%
ROIC/WACC1.1
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.11%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%10.53%
EPS Next Y11.28%
EPS Next 2Y10.75%
EPS Next 3Y10.76%
EPS Next 5Y9.87%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%7.37%
Revenue Next Year6.48%
Revenue Next 2Y7.16%
Revenue Next 3Y7.22%
Revenue Next 5Y7.08%
EBIT growth 1Y13.84%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.75%
EBIT Next 3Y15.65%
EBIT Next 5Y12.28%
FCF growth 1Y23.45%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y21.27%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%